Lia Gore Selected Research

Cytokines

9/2017	Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
6/2013	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lia Gore Research Topics

Disease

47	Neoplasms (Cancer) 01/2023 - 09/2006
35	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 12/2005
15	Leukemia 04/2024 - 12/2007
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2011
5	Neutropenia 10/2018 - 09/2008
5	Astrocytoma (Pilocytic Astrocytoma) 11/2017 - 09/2006
4	Lymphoma (Lymphomas) 11/2023 - 07/2008
4	Disease Progression 01/2021 - 03/2007
4	Fatigue 01/2019 - 09/2009
4	Thrombocytopenia (Thrombopenia) 09/2009 - 09/2008
3	Cytopenia 01/2022 - 06/2013
3	Infections 01/2021 - 03/2015
3	Febrile Neutropenia 01/2021 - 02/2009
3	Glioma (Gliomas) 01/2021 - 12/2009
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020 - 01/2017
3	Melanoma (Melanoma, Malignant) 11/2017 - 09/2006
3	Nausea 01/2017 - 02/2009
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2016 - 03/2007
2	Multiple Myeloma 12/2022 - 01/2019
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2022 - 01/2022
2	Hyperbilirubinemia 01/2022 - 08/2016
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 10/2018
2	Philadelphia Chromosome 11/2021 - 01/2021
2	Residual Neoplasm 01/2020 - 12/2016
2	Fever (Fevers) 10/2018 - 09/2009
2	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 09/2018 - 10/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 09/2014
2	Pericardial Effusion 01/2018 - 01/2016
2	Exanthema (Rash) 11/2017 - 08/2014
2	Brain Neoplasms (Brain Tumor) 09/2017 - 05/2015
2	Vomiting 01/2017 - 02/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2016 - 10/2010
2	Diffuse Intrinsic Pontine Glioma 11/2014 - 06/2013
2	Neuroblastoma 10/2014 - 03/2007
2	Bites and Stings (Sting) 01/2014 - 06/2013
2	Glioblastoma (Glioblastoma Multiforme) 06/2013 - 04/2007
2	Osteosarcoma (Osteogenic Sarcoma) 03/2007 - 06/2003
1	Hypertension (High Blood Pressure) 01/2022
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 11/2021
1	Acute Disease 11/2021

Drug/Important Bio-Agent (IBA)

9	blinatumomabIBA 01/2023 - 06/2013
5	AntibodiesIBA 01/2022 - 12/2008
4	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 02/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 12/2012
4	entinostat (MS 275)IBA 11/2021 - 07/2008
4	Monoclonal AntibodiesIBA 05/2014 - 06/2008
3	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2022
3	Histone Deacetylase InhibitorsIBA 11/2021 - 07/2008
3	Clofarabine (Clolar)FDA Link 11/2021 - 12/2012
3	Dasatinib (BMS 354825)FDA Link 01/2018 - 09/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 04/2007
3	Phosphotransferases (Kinase)IBA 05/2015 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 03/2014 - 01/2010
3	Capecitabine (Xeloda)FDA Link 10/2012 - 01/2008
2	Proteasome InhibitorsIBA 12/2022 - 01/2019
2	NucleosidesIBA 11/2022 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2016
2	Inotuzumab OzogamicinIBA 01/2022 - 01/2022
2	lestaurtinibIBA 05/2021 - 01/2021
2	TabletsIBA 01/2021 - 01/2018
2	Everolimus FDA Link 01/2021 - 01/2018
2	Azacitidine (5 Azacytidine)FDA Link 10/2020 - 01/2018
2	venetoclaxIBA 10/2020 - 09/2018
2	Decitabine FDA Link 01/2020 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 08/2017
2	CateninsIBA 03/2018 - 03/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2017 - 10/2009
2	Cetuximab (Erbitux)FDA Link 11/2017 - 10/2009
2	ErbB Receptors (EGF Receptor)IBA 11/2017 - 04/2012
2	CytokinesIBA 09/2017 - 06/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2016 - 03/2014
2	Messenger RNA (mRNA)IBA 05/2015 - 12/2009
2	Tyrosine Kinase InhibitorsIBA 09/2014 - 04/2012
2	vesencumabIBA 08/2014 - 05/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 09/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 12/2009 - 09/2008
2	Carboplatin (JM8)FDA LinkGeneric 09/2009 - 02/2009
2	phosphomannopentaose sulfateIBA 12/2008 - 09/2006
2	Gefitinib (Iressa)FDA Link 12/2008 - 09/2006
1	Anesthetics (Anesthetic Agents)IBA 04/2024
1	Cyclin DIBA 11/2023
1	palbociclibIBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 12/2022
1	carfilzomibIBA 12/2022
1	Plant NectarIBA 11/2022
1	nelarabine (506U78)FDA Link 11/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	CD19 AntigensIBA 01/2022
1	Ifosfamide FDA LinkGeneric 10/2021
1	Vincristine (Oncovin)FDA LinkGeneric 10/2021

Therapy/Procedure

33	Therapeutics 04/2024 - 06/2003
21	Drug Therapy (Chemotherapy) 11/2023 - 06/2008
3	Immunotherapy 10/2023 - 11/2021
2	Induction Chemotherapy 11/2023 - 12/2022
2	Hematopoietic Stem Cell Transplantation 01/2022 - 12/2007
1	Duration of Therapy 12/2022